Semaglutide, Originally Designed to Control Type 2 Diabetes, Shows Efficiency in Weight Loss Getty
It may interest you: The injectable drug for obesity will be available in Argentina
It may interest you: What is the link between artificial sweeteners and an increased risk of diabetes and metabolic syndrome
Wegovy™, marketed as semaglutide 2.4mg injection, has been approved for the treatment of obesity in the United States, Europe and several countries in Asia REUTERS/Jim Vondruska/Illustration/File Photo
It may interest you: Lose weight, be vegan or increase muscle: how to receive free personalized nutritional advice
Specialists emphasize the need to adopt a diet with fewer processed products and more fruits and vegetables, as an integral part of strategies to combat obesity Getty Images
Experts from Harvard University stress the importance of increasing physical activity as an essential part of the fight against obesity (Gettyimages)
Wegovy is the trade name of the drug semaglutide for the treatment of obesity, an analogue of GLP1, a hormone that is produced in the intestine after food intake REUTERS/Jim Vondruska/Illustration/File Photo
Semaglutide, originally designed for the treatment of type 2 diabetes, has been shown to be effective for weight loss and opens new horizons in the fight against obesity Getty
Experts noted that 10% of patients may have to stop treatment due to side effects Getty
The ‘gut-brain connection’ in obesity treatments reveals a complex interplay, where gut problems can lead to emotional symptoms (iStock)
Closer to a weight loss pill? A clinical trial with semaglutide showed encouraging results
The injectable drug for obesity will be available in Argentina
What is it and what are the risks of berberine, a natural compound used to lose weight
